(Q73676552)
Statements
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group (English)
W Koizumi
M Kurihara
S Nakano
scientific article published on 01 April 2000
No description defined